Protection from infection and reinfection due to the Omicron BA.1 variant in care homes
- PMID: 37936695
- PMCID: PMC10627010
- DOI: 10.3389/fimmu.2023.1186134
Protection from infection and reinfection due to the Omicron BA.1 variant in care homes
Abstract
Introduction: Following the emergence of SARS-CoV-2 in 2020, care homes were disproportionately impacted by high mortality and morbidity of vulnerable elderly residents. Non-pharmaceutical interventions (NPIs) and improved infection control measures together with vaccination campaigns have since improved outcomes of infection. We studied the utility of past infection status, recent vaccination and anti-S antibody titres as possible correlates of protection against a newly emergent Omicron variant infection.
Methods: Prospective longitudinal surveillance of nine sentinel London care homes from April 2020 onwards found that all experienced COVID-19 outbreaks due to Omicron (BA.1) during December 2021 and January 2022, despite extensive prior SARS-CoV-2 exposure and high COVID-19 vaccination rates, including booster vaccines (>70% residents, >40% staff).
Results: Detailed investigation showed that 46% (133/288) of Omicron BA.1 infections were SARS-CoV-2 reinfections. Two and three COVID-19 vaccine doses were protective against Omicron infection within 2-9 weeks of vaccination, though protection waned from 10 weeks post-vaccination. Prior infection provided additional protection in vaccinated individuals, approximately halving the risk of SARS-CoV-2 infection.
Discussion: Anti-S antibody titre showed a dose-dependent protective effect but did not fully account for the protection provided by vaccination or past infection, indicating that other mechanisms of protection are also involved.
Keywords: COVID-19; Omicron (BA1); SARS-CoV-2; care homes; correlate of protection; outbreaks; vaccine.
Copyright © 2023 Choudhry, Rowland, McClelland, Renz, Iyanger, Chow, Aiano, Ladhani, Jeffery-Smith, Andrews and Zambon.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Krutikov M, Stirrup O, Nacer-Laidi H, Azmi B, Fuller C, Tut G, et al. . Outcomes of SARS-CoV-2 Omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study. Lancet Healthy Longev (2022) 3(5):e347–55. doi: 10.1016/S2666-7568(22)00093-9 - DOI - PMC - PubMed
-
- Adult social care monthly statistics. England: GOV.UK; (2021). Available at: https://www.gov.uk/government/statistics/adult-social-care-in-england-mo....
-
- Weekly Flu and COVID-19 report week 1 2022.pdf . Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploa....
-
- UK Health Security Agency. SARS-CoV-2 variants of concern and variants under investigation in England: Technical briefing 35 (2022). Available at: htpps://assets.publishing.service.gov.uk/media/61f3c7388fa8f5388cafda99/Technica... (Accessed April 10, 2023).
-
- Jeffery-Smith A, Rowland TAJ, Patel M, Whitaker H, Iyanger N, Williams SV, et al. . Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England. Lancet Healthy Longev (2021) 2(12):e811–9. doi: 10.1016/S2666-7568(21)00253-1 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
